MSN Money - MarketWatch - Trading Markets (press release)
AMSTERDAM - US health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch biotechnology company Crucell NV for euro301.8 million ($440 million) in hopes to develop a universal flu vaccine, the companies said Monday.